Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 111

DEA Hemp Cultivation Advocacy 111

Cannabis Law Report

NOVEMBER 11, 2021

Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs.

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

SEPTEMBER 13, 2022

Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. Cultivation Costs for Homegrowers.

Cultivation 109

Cultivation Data DEA Dispensary 109

Veriheal

NOVEMBER 6, 2023

The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine. Wisconsin Wisconsin has no state medical cannabis program and no licensed medical Marijuana dispensaries.

Legalization 117

Legalization Recreational THC CBD 117

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Drug Enforcement Agency (DEA). territories. This means that U.S. federal law.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

JULY 13, 2021

Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . There will also be expanded tracking on purchases, and limited purchases, even for medical cannabis patients. .

Law 52

Law Patients DEA Access 52

The Blunt Truth

DECEMBER 29, 2023

As of now, this is still a proposal, and it’s anyone’s guess if the DEA (who would do the actual re-scheduling) will think that’s a good idea. In October , independent pharmacies in Georgia registered with the Georgia Board of Pharmacy to provide low THC oil to medical cannabis patients. But what about federal legislation ??

DEA 52

DEA Retail Legalization Food 52

MedicalJane

JUNE 29, 2018

The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

CannaMD

AUGUST 8, 2020

Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. ”, our first instinct is to remain patients that CBD is CBD.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

OCTOBER 31, 2019

The illicit extraction operation was detected by OLCC inspectors at an out-of-compliance Oregon Medical Marijuana Program (OMMP) medical grow site. Inspectors from the OLCC OMMP Marijuana Tracking Program were making a proactive check on the Lane County location which had been registered as an OMMP (GSA) grow site.

Oil 45

Oil Extraction Hash Marijuana 45

The Blunt Truth

OCTOBER 3, 2019

And Michigan is expanding the number of communities eligible for its social equity program. In other judicial news, a judge in New Mexico ruled that the state must accept non-residents into its medical marijuana program. They maintain that the limits will put constraints on the amount of marijuana available to patients.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Cannabis Law Report

MAY 2, 2019

Earl Blumenauer, D-Oregon, would allow VA health providers to recommend medical marijuana to their veteran patients and fill out the necessary paperwork for them to enroll in state marijuana programs. One, the Veterans Equal Access Act, H.R. 1647, sponsored by Rep. Full story at [link].

DEA 45

DEA Law Legislation Programs 45

Canna Care Docs

SEPTEMBER 26, 2019

Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. Evaluate patient for verification of a qualifying condition. WE ARE SEEKING LICENSED MD OR ARPNs for our Hartford, CT clinic.

History 40

History DEA Therapy Patients 40

CannaMD

MAY 6, 2020

However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. Visiting Qualifying Patients. Planning a vacation should be fun.

Hash 103

Hash Legalization Marijuana Concentrates 103

The Blunt Truth

MARCH 5, 2020

Lawmakers wrestled with the issue of capping THC content in medical marijuana for those patients under the age of 21. They see legalization as a solution to problems with the medical cannabis program. The Department of Agriculture delayed a requirement that the DEA conduct all THC testing on hemp crops. FEDERAL NEWS.

Banking 99

Banking DEA THC Hemp 99

SpeedWeed

AUGUST 11, 2021

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. This trial will be the second of its kind to be conducted so far, and one that is an FDA- and DEA-regulated double-blind, placebo-controlled study. The study was funded with $2.2

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” According to the DAV, veterans who are involved in the medical cannabis program in legalized states will still enjoy their VA benefits. Yes, it has.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 13, 2022

1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. Previously, such patients were limited to only non-smokable preparations of marijuana (such as gummies) and cannabis preparations administered via “metered-dose inhaler.”. Louisiana: As of Jan. California: As of Jan.

Dispensary 52

Dispensary Law Concentrates Patients 52

PrestoDoctor

FEBRUARY 6, 2023

The doctor must be registered with the Oklahoma Medical Marijuana program. Other states have a list of qualifying conditions that the patients must meet to get an MMJ. Finally, you will complete the application and get charged for your appointment (patients only pay if approved!). Your patient status remains confidential.

Marijuana 52

Marijuana Patients Conditions Access 52

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. ABOUT MAPS PUBLIC BENEFIT CORPORATION (MAPS PBC) .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. Other states have a list of conditions that the patients must meet to get an MMJ. Will I Be Put on a List?

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. Other states have a list of conditions that the patients must meet to get an MMJ. Will I Be Put on a List?

Marijuana 52

Marijuana Patients Conditions Programs 52

Veriheal

JUNE 29, 2021

The FDA refers to this program as the expanded access program on their website. While they offer approved clinical trials that can offer patients the ability to try potential therapeutic options, many patients are unable to participate in clinical trials, and this is where the importance of the Right to Try programs comes into play.

Therapy 55

Therapy DEA Patients Clinical Trials 55

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. It was also after the Vietnam War that widespread ketamine abuse would begin to show up as a party drug. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

MARCH 3, 2022

He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs. Also in spite of pleas to reduce the racially disparate crack-cocaine sentencing disparity, for example, the former president took no action to remediate the issue.

Media 52

Media CBD Events THC 52

SpeedWeed

MARCH 5, 2021

Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Further, substances in these scheduling categories are only available to patients under the prescription of a physician – therefore making such a classification inapplicable to cannabis in those states that regulate its adult use.

Business 52

Business Policy Clinical Trials Research and Development 52

The Herb Collective

JUNE 25, 2018

According to Trend Statistics, there are over 2,604,079 medical marijuana patients in 2016, with 19.8 patients per thousand residents in Colorado, 19.4 patients per thousand residents in Phoenix AZ, Las Vegas NV, and California, and 19.2 patients per thousand residents in Washington and Oregon. Source: Cannabisser) 10.

Marijuana 56

Marijuana Edibles Recreational Strains 56

Canna Law Blog

SEPTEMBER 28, 2019

Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. IDEA requires that schools provide special education services as outlined in a student’s Individualized Education Program (“IEP”).

Education 62

Education Oil DEA Cannabis 62

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

Canna Law Blog

MAY 7, 2020

What you may not know is that the federal government actually has its own stash of cannabis for limited patient distribution and limited research purposes that it houses at the University of Mississippi (a/k/a) Ole Miss in Oxford, Mississippi. These cannabis products are used by researchers in the U.S.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

CannaMD

SEPTEMBER 10, 2020

This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.

Marijuana 59

Marijuana Therapy Data THC 59